EUR/CAD (EURCAD=X)

CCY - CCY Delayed Price. Currency in CAD

Add to watchlist

1.3519

-0.0104

(-0.7642%)

As of 02:41PM BST. Market open.

Advertisement

Business Wire
Vertex Reports First Quarter 2022 Financial Results
BOSTON, May 05, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the first quarter ended March 31, 2022 and reiterated full year 2022 product revenue guidance.
Simply Wall St.
Those who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) five years ago are up 137%
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
American City Business Journals
Here's how much Vertex Pharmaceuticals' CEO took home last year
Vertex Pharmaceuticals Inc.'s Reshma Kewalramani made $15.2 million in her first full year as CEO of Massachusetts' fourth-largest life sciences employer. Vertex (Nasdaq: VRTX) disclosed Kewalramani's compensation in a securities filing late Thursday. Like all executives, Kewalramani's total pay is a combination of base salary, stock awards and other compensation.